Faculty Opinions recommendation of HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.

2015 ◽  
Author(s):  
Gerd Kullak-Ublick
Keyword(s):  
Breast Cancer ◽  
Risk Factor ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Major Risk Factor ◽  
Hla Dqa1

scholarly journals Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

2014 ◽  
Vol 111 (11) ◽  
pp. 2051-2057 ◽  
Author(s):  
T Brodowicz ◽  
I Lang ◽  
Z Kahan ◽  
R Greil ◽  
S Beslija ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factor ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Factor Analyses ◽  
First Line

Relationship of HLA-DQA1*0201 and lapatinib-induced hepatotoxicity in women with advanced breast cancer.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 3100-3100 ◽  
Author(s):  
C. F. Spraggs ◽  
L. R. Budde ◽  
L. P. Briley ◽  
N. Bing ◽  
A. J. Preston ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Hla Dqa1 ◽  
Relationship Of

Gemcitabine, epirubicin, and paclitaxel combinations in advanced breast cancer

2001 ◽  
Vol 28 (2D) ◽  
pp. 15-17
Author(s):  
PierFranco Conte ◽  
Barbara Salvadori ◽  
Sara Donati ◽  
Elisabetta Landucci ◽  
Alessandra Gennari
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast

New cytotoxic agents and schedules for advanced breast cancer

2001 ◽  
Vol 28 (4) ◽  
pp. 344-358 ◽  
Author(s):  
Harold J. Burstein ◽  
Craig A. Bunnell ◽  
Eric P. Winer
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Cytotoxic Agents
Sign in / Sign up

Export Citation Format

Share Document